RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that P. Kay Wagoner, Ph.D., President and Chief Executive Officer, will participate in the 2008 BioBusiness Conference to be held February 26 through February 28, 2008 in Geneva. Dr. Wagoner and Jeff Southerton, Ph.D., Executive Director, Worldwide Business Development at Pfizer, are scheduled to present an overview of the companies’ collaborative pain program, “Evaluating the Impact of a High-Profile Collaboration on Pain Treatments” on Thursday, February 28, 2008.
